Purdue Sees Another OxyContin Patent Axed

By Andrew Karpan · September 9, 2024, 9:39 PM EDT

A Delaware federal court decided on Monday that yet another patent issued to bankrupt OxyContin maker Purdue Pharma is invalid, a year and a half after a similar ruling was issued...

To view the full article, register now.

Documents

Case Information

Case Title

Purdue Pharma L.P. et al v. Accord Healthcare Inc.

Case Number

1:22-cv-00913

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

July 08, 2022